Bioactivity:

AT-130 is a HBV virus inhibitor with improved potency (IC50 = 0.13 _M) and reduced toxicity in the HepAD38 cell line. AT-130 blocks HBV replication at the level of viral RNA packaging.

CAS nr:

211364-06-6

Purity:

98%

Molecular Weight:

488,33

SMILES:

COc(cccc1)c1C(Br)=C(C(N1CCCCC1)=O)NC(c(cc1)ccc1[N+]([O-])=O)=O

Formula:

C22H22BrN3O5

Pathway:

DNA Damage/DNA Repair,Cell Cycle/Checkpoint,Microbiology/Virology

Target:

DNA/RNA Synthesis,DNA/RNA Synthesis,HBV